Schulhoff & Co. Inc. Cuts Stake in Hill-Rom Holdings, Inc. (HRC)
Schulhoff & Co. Inc. lessened its holdings in Hill-Rom Holdings, Inc. (NYSE:HRC) by 8.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 5,680 shares of the medical technology company’s stock after selling 520 shares during the quarter. Schulhoff & Co. Inc.’s holdings in Hill-Rom were worth $502,000 as of its most recent SEC filing.
Other hedge funds have also made changes to their positions in the company. Oakbrook Investments LLC raised its position in Hill-Rom by 34.5% during the third quarter. Oakbrook Investments LLC now owns 8,967 shares of the medical technology company’s stock worth $846,000 after acquiring an additional 2,300 shares in the last quarter. LSV Asset Management bought a new stake in Hill-Rom during the third quarter worth $715,000. Vanguard Group Inc raised its position in Hill-Rom by 0.6% during the third quarter. Vanguard Group Inc now owns 5,916,827 shares of the medical technology company’s stock worth $558,549,000 after acquiring an additional 34,369 shares in the last quarter. TIAA CREF Investment Management LLC raised its position in Hill-Rom by 2.1% during the third quarter. TIAA CREF Investment Management LLC now owns 192,606 shares of the medical technology company’s stock worth $18,182,000 after acquiring an additional 4,010 shares in the last quarter. Finally, Virtu Financial LLC bought a new stake in Hill-Rom during the fourth quarter worth $299,000. 86.96% of the stock is currently owned by institutional investors and hedge funds.
Several analysts have issued reports on HRC shares. Zacks Investment Research lowered shares of Hill-Rom from a “buy” rating to a “hold” rating in a research report on Wednesday, November 14th. Morgan Stanley dropped their price target on shares of Hill-Rom from $100.00 to $98.00 and set an “equal weight” rating on the stock in a research report on Wednesday, January 2nd. Finally, ValuEngine lowered shares of Hill-Rom from a “buy” rating to a “hold” rating in a research report on Wednesday, January 2nd. Four analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. The stock has an average rating of “Buy” and an average price target of $102.67.
Shares of HRC traded up $1.04 during trading hours on Monday, hitting $104.61. The company had a trading volume of 554,155 shares, compared to its average volume of 570,253. The firm has a market capitalization of $6.97 billion, a PE ratio of 22.02, a PEG ratio of 1.46 and a beta of 0.95. Hill-Rom Holdings, Inc. has a 12 month low of $80.70 and a 12 month high of $105.78. The company has a debt-to-equity ratio of 1.17, a current ratio of 1.70 and a quick ratio of 1.25.
Hill-Rom (NYSE:HRC) last issued its quarterly earnings data on Friday, January 25th. The medical technology company reported $1.02 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.98 by $0.04. The company had revenue of $683.50 million for the quarter, compared to analyst estimates of $676.39 million. Hill-Rom had a net margin of 7.21% and a return on equity of 21.23%. The company’s revenue was up 2.1% on a year-over-year basis. During the same period in the prior year, the firm earned $0.92 earnings per share. Analysts predict that Hill-Rom Holdings, Inc. will post 5.06 earnings per share for the current fiscal year.
Hill-Rom Company Profile
Hill-Rom Holdings, Inc operates as a medical technology company worldwide. It operates in three segments: Patient Support Systems, Front Line Care, and Surgical Solutions. The company offers medical surgical beds, intensive care unit beds, and bariatric patient beds, lifts and other patient mobility devices, non-invasive therapeutic products and surfaces, and information technologies and software solutions; and medical equipment management services, as well as sells equipment service contracts for its capital equipment.
Featured Story: What is a stock split?
Receive News & Ratings for Hill-Rom Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom and related companies with MarketBeat.com's FREE daily email newsletter.